The apsytic pharmaceutical manufacturing (APM) technology, which aims to manufacture pharmaceuticals from renewable sources, has been around for years and is still used in some of the world’s biggest pharmaceutical manufacturing companies.
Now, a new APM startup called Aperpetuus is trying to make the process more widely available.
“The idea is to get people to invest in APM technology so that it becomes a real viable option for manufacturing, in other words making a lot more pharmaceuticals out of renewables,” Aperpotus cofounder David Kowalewski told The Huffington Press.
“We’ve been working on this for quite a while.”
For the last year, Aperpus has been working with other startup companies to build a new type of APM manufacturing system that could be used for industrial processes such as those that would be used to produce a lot of pharmaceuticals.
“We’re trying to get a manufacturing platform for the whole world, and we’ve been developing our technology to the point where we can actually scale up to the big guys and really bring it into production,” Kowalewski said.
The Aperpots APM solution uses a process called APMS (atmospheric oxygen capture and fixation), which Kowalkowski said would allow for a lot less production of raw materials and other resources.
This would be important because the pharmaceutical industry relies heavily on raw materials like platinum, which can be very expensive to obtain.
“This would also help us make the products we’re making cheaper to use and to process,” he said.
Kowaleksi added that APM is a really good alternative to the current process of making pharmaceuticals in the laboratory, which has a large amount of raw material to process and is expensive.
“There’s so much waste that goes on in the lab,” Kewalkowski explained.
“The process that goes into making a pill has a lot to do with this waste.
That’s why it’s really important to have a way to recycle the waste.
APM would be a really great alternative for that, because we would not be using that waste.”APM can also be used in manufacturing processes that use carbon dioxide to manufacture raw materials, such as in manufacturing a plant that converts carbon dioxide into a pharmaceutical-grade product.
The company has been testing this process for several years in various factories around the world.”APM is really easy to do, and you can scale it up very quickly,” KOWalkowski told The Associated Press.
In addition to manufacturing pharmaceuticals, Kowanki said APM could also be utilized to produce solar energy and other renewable energy.
The company has already secured $3 million in seed funding and is now looking to raise more funding.
Kowako said it is currently working with a few companies, but none of them are large companies, which makes the process very challenging.
“If you don’t have a huge company, you’re just going to have to build this out,” Koweanki explained.
He said that the company hopes to have the first production of the APM system available by the end of the year.